Defining preventive cardiology: A clinical practice statement from the American Society for Preventive Cardiology

被引:18
作者
German, Charles A. [1 ]
Baum, Seth J. [2 ]
Ferdinand, Keith C. [3 ]
Gulati, Martha [4 ]
Polonsky, Tamar S. [1 ]
Toth, Peter P. [5 ,6 ]
Shapiro, Michael D. [7 ]
机构
[1] Univ Chicago, Dept Med, Sect Cardiol, Chicago, IL 60637 USA
[2] Florida Atlantic Univ, Charles & Schmidt Coll Med, Dept Integrated Med Sci, Boca Raton, FL 33431 USA
[3] Tulane Univ, Sch Med, Tulane Heart & Vasc Inst, New Orleans, LA 70112 USA
[4] Cedars Sinai Med Ctr, Barbra Streisand Womens Heart Ctr, Smidt Heart Inst, Los Angeles, CA 90048 USA
[5] Johns Hopkins Univ, Sch Med, Cicarrone Ctr Prevent Cardiovasc Dis, Baltimore, MD USA
[6] CGH Med Ctr, Sterling, IL USA
[7] Wake Forest Univ, Bowman Gray Sch Med, Sect Cardiovasc Med, Ctr Prevent Cardiovasc Dis, Winston Salem, NC USA
来源
AMERICAN JOURNAL OF PREVENTIVE CARDIOLOGY | 2022年 / 12卷
关键词
Preventive cardiology; Atherosclerosis; Primordial prevention; Primary prevention; Secondary prevention; Risk assessment; Cardiovascular disease; CORONARY-HEART-DISEASE; CARDIOVASCULAR RISK-FACTORS; ARTERY CALCIUM; PHYSICAL-ACTIVITY; SCIENTIFIC STATEMENT; METABOLIC SYNDROME; MYOCARDIAL-INFARCTION; SECONDARY PREVENTION; LDL-CHOLESTEROL; CARDIAC REHABILITATION;
D O I
10.1016/j.ajpc.2022.100432
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Remarkable transformations in science and healthcare have resulted in declines in mortality from cardiovascular disease over the past several decades, largely driven by progress in prevention and treatment of persons at risk. However, these trends are now beginning to stall, as our county faces increases in cardiovascular risk factors including overweight and obesity, type 2 diabetes mellitus, and metabolic syndrome. Furthermore, poor long-term adherence to a healthy lifestyle and lifesaving pharmacotherapy have exacerbated these trends, with recent data suggesting unprecedented increases in cardiovascular morbidity and mortality. A paradigm shift is needed to improve the cardiovascular health of our nation. Preventive cardiology, a growing subspecialty of cardiovascular medicine, is the practice of primordial, primary, and secondary prevention of all cardiovascular diseases. Preventive cardiologists and preventive cardiology specialists are well equipped with the knowledge and skill-set necessary to reduce deaths related to the growing burden of heart disease and its risk factors. Despite dedicated efforts, cardiovascular disease remains the leading killer of men and women in the United States. Although there is little debate regarding the importance of prevention, many healthcare professionals question the need for preventive cardiology as a distinct subspecialty. Additionally, the field's growth has been hampered by a lack of organization and standardization, and variability of training within programs across the country. The purpose of this document is to delineate the key attributes that define the field of preventive cardiology according to the American Society for Preventive Cardiology.
引用
收藏
页数:12
相关论文
共 166 条
  • [1] Increasing Cardiac Rehabilitation Participation From 20% to 70%: A Road Map From the Million Hearts Cardiac Rehabilitation Collaborative
    Ades, Philip A.
    Keteyian, Steven J.
    Wright, Janet S.
    Hamm, Larry F.
    Lui, Karen
    Newlin, Kimberly
    Shepard, Donald S.
    Thomas, Randal J.
    [J]. MAYO CLINIC PROCEEDINGS, 2017, 92 (02) : 234 - 242
  • [2] Value of Coronary Artery Calcium Scanning in Association With the Net Benefit of Aspirin in Primary Prevention of Atherosclerotic Cardiovascular Disease
    Ajufo, Ezimamaka
    Ayers, Colby R.
    Vigen, Rebecca
    Joshi, Parag H.
    Rohatgi, Anand
    de Lemos, James A.
    Khera, Amit
    [J]. JAMA CARDIOLOGY, 2021, 6 (02) : 179 - 187
  • [3] Metabolic syndrome - a new world-wide definition. A consensus statement from the international diabetes federation
    Alberti, KGMM
    Zimmet, P
    Shaw, J
    [J]. DIABETIC MEDICINE, 2006, 23 (05) : 469 - 480
  • [4] 9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2022
    American Diabetes Association Professional Practice Committee
    [J]. DIABETES CARE, 2022, 45 : S125 - S143
  • [5] Rivaroxaban with or without aspirin in patients with stable peripheral or carotid artery disease: an international, randomised, double-blind, placebo-controlled trial
    Anand, Sonia S.
    Bosch, Jackie
    Eikelboom, John W.
    Connolly, Stuart J.
    Diaz, Rafael
    Widimsky, Peter
    Aboyans, Victor
    Alings, Marco
    Kakkar, Ajay K.
    Keltai, Katalin
    Maggioni, Aldo P.
    Lewis, Basil S.
    Stoerk, Stefan
    Zhu, Jun
    Lopez-Jaramillo, Patricio
    O'Donnell, Martin
    Commerford, Patrick J.
    Vinereanu, Dragos
    Pogosova, Nana
    Ryden, Lars
    Fox, Keith A. A.
    Bhatt, Deepak L.
    Misselwitz, Frank
    Varigos, John D.
    Vanassche, Thomas
    Avezum, Alvaro A.
    Chen, Edmond
    Branch, Kelley
    Leong, Darryl P.
    Bangdiwala, Shrikant I.
    Hart, Robert G.
    Yusuf, Salim
    [J]. LANCET, 2018, 391 (10117) : 219 - 229
  • [6] Empagliflozin in Heart Failure with a Preserved Ejection Fraction
    Anker, Stefan D.
    Butler, Javed
    Filippatos, Gerasimos
    Ferreira, Joao P.
    Bocchi, Edimar
    Boehm, Michael
    Brunner-La Rocca, Hans-Peter
    Choi, Dong-Ju
    Chopra, Vijay
    Chuquiure-Valenzuela, Eduardo
    Giannetti, Nadia
    Gomez-Mesa, Juan Esteban
    Janssens, Stefan
    Januzzi, James L.
    Gonzalez-Juanatey, Jose R.
    Merkely, Bela
    Nicholls, Stephen J.
    Perrone, Sergio V.
    Pina, Ileana L.
    Ponikowski, Piotr
    Senni, Michele
    Sim, David
    Spinar, Jindrich
    Squire, Iain
    Taddei, Stefano
    Tsutsui, Hiroyuki
    Verma, Subodh
    Vinereanu, Dragos
    Zhang, Jian
    Carson, Peter
    Lam, Carolyn Su Ping
    Marx, Nikolaus
    Zeller, Cordula
    Sattar, Naveed
    Jamal, Waheed
    Schnaidt, Sven
    Schnee, Janet M.
    Brueckmann, Martina
    Pocock, Stuart J.
    Zannad, Faiez
    Packer, Milton
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (16) : 1451 - 1461
  • [7] Physical Activity Guidelines Advisory Committee Report, 2008
    不详
    [J]. NUTRITION REVIEWS, 2009, 67 (02) : 114 - 120
  • [8] Arnett DK, 2019, CIRCULATION, V140, pE596, DOI [10.1161/CIR.0000000000000677, 10.1016/j.jacc.2019.03.010, 10.1161/CIR.0000000000000678, 10.1016/j.jacc.2019.03.009]
  • [9] Redefining Hypertension - Assessing the New Blood-Pressure Guidelines
    Bakris, George
    Sorrentino, Matthew
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2018, 378 (06) : 497 - 499
  • [10] Assessing the Impact of Medication Adherence on Long-Term Cardiovascular Outcomes
    Bansilal, Sameer
    Maria Castellano, Jose
    Garrido, Ester
    Wei, Henry G.
    Freeman, Allison
    Spettell, Claire
    Garcia-Alonso, Fernando
    Lizano, Irene
    Arnold, Renee J. G.
    Rajda, Jay
    Steinberg, Gregory
    Fuster, Valentin
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2016, 68 (08) : 789 - 801